Psychiatry Investig.
2022 Jun;19(6):500-500. 10.30773/pi.2021.0368e.
Acute Efficacy and Safety of Escitalopram Versus Desvenlafaxine and Vortioxetine in the Treatment of Depression With Cognitive Complaint: A Rater-Blinded Randomized Comparative Study
- Affiliations
-
- 1Department of Psychiatry, Veterans Health Service Medical Center, Seoul, Republic of Korea
- 2Department of Psychiatry, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
- 3Department of Psychiatry, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Republic of Korea
- 4Department of Psychiatry, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
- 5Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, USA
- 6Global Medical Education, New York, NY, USA
- 7Department of Biostatistics, Korea University College of Medicine, Seoul, Republic of Korea
- 8Department of Psychiatry, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Republic of Korea
- KMID: 2530625
- DOI: http://doi.org/10.30773/pi.2021.0368e
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Acute Efficacy and Safety of Escitalopram Versus Desvenlafaxine and Vortioxetine in the Treatment of Depression With Cognitive Complaint: A Rater-Blinded Randomized Comparative Study
- Efficacy and Safety of Escitalopram, Desvenlafaxine, and Vortioxetine in the Acute Treatment of Anxious Depression: A Randomized Rater-blinded 6-week Clinical Trial
- Vortioxetine Treatment for Depression in Alzheimer’s Disease: A Randomized, Double-blind, Placebo-controlled Study
- Paroxetine versus Venlafaxine and Escitalopram in Korean Patients with Major Depressive Disorder: A Randomized, Rater-blinded, Six-week Study
- Potential Effect of Vortioxetine on Restless Leg Syndrome
